Skip to content

In vivo CAR-T shows promise but questions remain
Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer
Jean-Marie Michot, MD, discusses the phase 3 Olympia-3 study
Australia TGA approves tafasitamab combo in relapsed, refractory FL
Global trial gaps in representation complicate US drug approvals

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Cellular Therapy

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Leukemia

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Lymphoma

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Multiple Myeloma

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Myelodysplastic Syndromes

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

May 1, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Myelodysplastic Syndromes

MDS News

GGM YT

ASH 2025 Myelodysplastic Syndromes

Dr. Garcia-Manero presents phase 2 ASTX030 results in MDS and other blood cancers

by SOHO Insider Editors
January 15, 2026
0 Comments

Leukemia Chronic Myeloid Leukemia Myelodysplastic Syndromes News

Pathways & Perspectives with Valeria Santini, MD

by Leah Sherwood
November 25, 2025
0 Comments

FDA editorial

Myelodysplastic Syndromes News

FDA grants orphan drug designation to MDS investigational therapy ofirnoflast

by SOHO Insider Editors
October 23, 2025
0 Comments

Digital tools

ESMO 2025 Acute Lymphoblastic Leukemia Aggressive B-Cell Lymphomas Multiple Myeloma Myelodysplastic Syndromes

Despite digital advances, cancer research remains costly, burdensome

by Leah Sherwood
October 22, 2025
0 Comments

Update

ESMO 2025 Myelodysplastic Syndromes News

Bexmarilimab continues to show strong efficacy in phase 1/2 trial update

by Leah Sherwood
October 21, 2025
0 Comments

Presenter speaking

Ambassador Program Myelodysplastic Syndromes Society Updates

SOHO MENA returns to in-person meeting for region’s 3rd meeting

by SOHO Insider Editors
October 20, 2025
0 Comments

Uma Borate presentation

SOHO 2025 Educational Resources Leukemia Meetings / Conferences Myelodysplastic Syndromes News

Improving Outcomes in CHIP/CCUS with Dr. Borate

by SOHO Insider Editors
October 20, 2025
0 Comments

FDA stamp on white paper

Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Myelodysplastic Syndromes News

FDA accepts BLA for Orca-T in hematological malignancies

by SOHO Insider Editors
October 15, 2025
0 Comments

Time for Phase 2. Hand holds a cube with number '2'. Word 'Phase 2'. Beautiful black background. Business concept. Copy space.

Acute Myeloid Leukemia Myelodysplastic Syndromes

Oral decitabine and cedazuridine combo shows promise as post-HSCT option

by Leah Sherwood
August 21, 2025
0 Comments

a globe

Acute Myeloid Leukemia Myelodysplastic Syndromes

Treatment post-relapse improves survival outcomes in patients with AML or MDS

by SOHO Insider Editors
August 11, 2025
0 Comments

1
2
3
4

Top Categories

Cellular Therapy

69

Leukemia

106

Lymphoma

119

Multiple Myeloma

92

Myelodysplastic Syndromes

36

Myeloproliferative Neoplasms

21

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Cellular Therapy

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Leukemia

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Lymphoma

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Multiple Myeloma

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Myelodysplastic Syndromes

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Myeloproliferative Neoplasms

Subscribe

Recent Posts

IV therapy; CAR-T

In vivo CAR-T shows promise but questions remain

SOHO Insider podcast

Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer

Phase 3 Olympia-3 study-BW

Jean-Marie Michot, MD, discusses the phase 3 Olympia-3 study

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.